Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChimeriVax-WN02 West Nile Vaccine in Healthy Adults
NCT00442169Phase 2Completed
- Sponsor
- Sanofi
- Start
- Dec 2005
- Primary completion
- Jun 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ChimeriVax-WN02 in West Nile fever, sponsored by Sanofi. Started Dec 2005; status: completed.
02
Drugs
ChimeriVax-WN02
03
Conditions
West Nile fever
Beyond the preview
Go deeper on NCT00442169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442169.